BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19476383)

  • 1. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
    Walsh P; Yau J; Simonetti K; Sharpe S
    Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126).
    Walsh P; Neudecker P; Sharpe S
    J Am Chem Soc; 2010 Jun; 132(22):7684-95. PubMed ID: 20465257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
    Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
    Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein.
    Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC
    J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly accelerated self-assembly and fibrillation of prion peptides on solid surfaces.
    Ku SH; Park CB
    Langmuir; 2008 Dec; 24(24):13822-7. PubMed ID: 19053635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of amyloid fibrils formed by the prion protein derived peptides PrP(244-249) and PrP(245-250).
    Yau J; Sharpe S
    J Struct Biol; 2012 Nov; 180(2):290-302. PubMed ID: 22929126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure of amyloid fibrils formed by residues 127 to 147 of the human prion protein.
    Lin NS; Chao JC; Cheng HM; Chou FC; Chang CF; Chen YR; Chang YJ; Huang SJ; Chan JC
    Chemistry; 2010 May; 16(18):5492-9. PubMed ID: 20358555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core.
    Wasmer C; Lange A; Van Melckebeke H; Siemer AB; Riek R; Meier BH
    Science; 2008 Mar; 319(5869):1523-6. PubMed ID: 18339938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study.
    Di Natale G; Impellizzeri G; Pappalardo G
    Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
    Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
    Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Helix is a likely core structure of yeast prion Sup35 amyloid fibers.
    Kishimoto A; Hasegawa K; Suzuki H; Taguchi H; Namba K; Yoshida M
    Biochem Biophys Res Commun; 2004 Mar; 315(3):739-45. PubMed ID: 14975763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of the human prion peptide 106-126 aggregation.
    Hanan E; Goren O; Eshkenazy M; Solomon B
    Biochem Biophys Res Commun; 2001 Jan; 280(1):115-20. PubMed ID: 11162487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cylinder-shaped double ribbon structure formed by an amyloid hairpin peptide derived from the beta-sheet of murine PrP: an X-ray and molecular dynamics simulation study.
    Croixmarie V; Briki F; David G; Coïc YM; Ovtracht L; Doucet J; Jamin N; Sanson A
    J Struct Biol; 2005 Jun; 150(3):284-99. PubMed ID: 15890277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.